KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $107

KeyBanc维持Alcon(ALC.US)买入评级，上调目标价至107美元

moomoo资讯 · 10/15 07:31 · 评级/大行评级

KeyBanc analyst Brett Fishbin maintains $Alcon (ALC.US)$ with a buy rating, and adjusts the target price from $96 to $107.

According to TipRanks data, the analyst has a success rate of 94.1% and a total average return of 22.3% over the past year.

AnalystRecentRatingAutoNews_77283641728636_20241015_b29bdbba70249ee55c0b8e740af7a70646288adc_1729071108403886_mm_en

Furthermore, according to the comprehensive report, the opinions of $Alcon (ALC.US)$'s main analysts recently are as follows:

The firm maintains a positive outlook on Alcon, expecting a mid-to-high single-digits growth trajectory into the second half of 2024/2025. This optimism is based on continuous market expansion at approximately 5%, along with multiple factors specific to the company. Additionally, the company seems well-prepared to reach its mid-20s EBIT margin goal by the year 2027.
The MedTech sector experienced solid returns, particularly as healthcare providers outperformed within the healthcare sub-sectors. This performance is consistent with the fundamental feedback during Q3, where procedure volumes remained robust and demand was strong. Further research indicates that the sustained demand for procedures is likely to continue into 2025, bolstered by demographic trends and low unemployment rates.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

KeyBanc分析师Brett Fishbin维持$Alcon (ALC.US)$买入评级，并将目标价从96美元上调至107美元。

根据TipRanks数据显示，该分析师近一年总胜率为94.1%，总平均回报率为22.3%。

AnalystRecentRatingAutoNews_77283641728636_20241015_b29bdbba70249ee55c0b8e740af7a70646288adc_1729071108403886_mm_sc

此外，综合报道，$Alcon (ALC.US)$近期主要分析师观点如下：

该公司对爱尔康保持乐观的前景，预计到2024/2025年下半年将呈中高个位数的增长轨迹。这种乐观情绪是基于市场持续扩张约5％，以及公司特有的多种因素。此外，该公司似乎已为到2027年实现其20年代中期的息税前利润率目标做好了充分的准备。
医疗科技行业获得了可观的回报，尤其是在医疗保健子行业中医疗保健提供商的表现跑赢大盘的情况下。这一表现与第三季度的基本反馈一致，该季度的手术量保持强劲，需求强劲。进一步的研究表明，在人口趋势和低失业率的推动下，对手术的持续需求可能会持续到2025年。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $107

KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $107

风险及免责提示

声明